Dynamic Biotechnology & Genome Invesco ETF (NY: PBE )
69.50
USD
-1.57
(-2.21%)
Official Closing Price
Updated: 6:30 PM EST, Mar 8, 2021
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
Analysts See 17% Upside For The Holdings of PBE
March 03, 2021
PerformanceMore NewsRead More
We Did The Math PBE Can Go To $82
January 28, 2021
PBE's Holdings Imply 11% Gain Potential
December 30, 2020
Biopharma Here to Stay: The Long-Term Case for the PBE ETF
January 20, 2021
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
December 14, 2020
Add Up The Parts: PBE Could Be Worth $77
December 14, 2020
Look Under The Hood: PBE Has 22% Upside
November 17, 2020
Implied PBE Analyst Target Price: $75
October 13, 2020
PBE's Holdings Imply 31% Gain Potential
October 05, 2020
3 Health Care ETFs Where Components Are Enduring Downgrades
September 25, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
